These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30056245)

  • 1. Consistency of listed indications and contraindications between the U.S., the U.K., Japan, and Korea on prescription drug labels.
    Yoon D; Song I; Noh Y; Li J; Shin JY
    Regul Toxicol Pharmacol; 2018 Oct; 98():168-170. PubMed ID: 30056245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies in the Evidence and Recommendation Levels of Pregnancy Information in Prescription Drug Labeling in the United States, United Kingdom, Japan, and Korea.
    Noh Y; Yoon D; Song I; Jeong HE; Bae JH; Shin JY
    J Womens Health (Larchmt); 2018 Sep; 27(9):1086-1092. PubMed ID: 29878862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Consistency of Drug Interaction Information in Drug Labels Among the United States, the United Kingdom, China, Japan, and Korea.
    Jeong S; Kam G; Li J; Lee S; Lee H; Noh Y; Shin JY
    Clin Pharmacol Ther; 2019 Feb; 105(2):505-514. PubMed ID: 29953578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement of label information of cardiovascular drugs in pregnancy among Korea, the USA, the UK, and Japan.
    Lee SH; Shin JY; Park MJ; Park BJ
    Regul Toxicol Pharmacol; 2014 Apr; 68(3):363-9. PubMed ID: 24513085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related off-label drug prescribing in pediatric patients in South Korea and consistency of labeling compared to the United States, Europe, and Japan.
    Park B; Lee H; Choi H; Lee J
    Clin Transl Sci; 2024 Jul; 17(7):e13869. PubMed ID: 38946123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety information in drug labeling: a comparison of the USA, the UK, and Japan.
    Shimazawa R; Ikeda M
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):306-18. PubMed ID: 23355452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United States.
    Song YK; Han N; Burckart GJ; Oh JM
    Clin Pharmacol Ther; 2020 Mar; 107(3):530-540. PubMed ID: 31544241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notable Differences in Drug Lag Between Korea and Japan of New Drugs Between 2009 and 2017.
    Lee SW; Park SH; Song I; Noh Y; Park H; Ha D; Shin JY
    Ther Innov Regul Sci; 2020 Mar; 54(2):418-423. PubMed ID: 32072585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of Pediatric Drug Approval and Clinical Evidence Submitted to Regulatory Authorities: International Comparison Among Japan, the United States, and the European Union.
    Hirota S; Yamaguchi T
    Clin Pharmacol Ther; 2020 Nov; 108(5):985-994. PubMed ID: 31869436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities and differences between US and Japan as to pharmacogenomic biomarker information in drug labels.
    Otsubo Y; Asahina Y; Noguchi A; Sato Y; Ando Y; Uyama Y
    Drug Metab Pharmacokinet; 2012; 27(1):142-9. PubMed ID: 22201121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different indications, warnings and precautions, and contraindications for the same drug--an international comparison of prescribing information for commonly used psychiatric drugs.
    Pfistermeister B; Schenk C; Kornhuber J; Bürkle T; Fromm MF; Maas R
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):329-33. PubMed ID: 23280570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between the United States and Japan in labels of oncological drugs.
    Jayaputra K; Ono S
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):143-151. PubMed ID: 27670850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Does "Regulatory Practice" Create Discrepancies in Drug Label Information Between Asian and Western Countries? Different Label Information for Direct Oral Anticoagulants Approved in the United States, Europe, Korea, and Japan.
    Cho IY; Choi KH; Sheen YY
    Ther Innov Regul Sci; 2019 Mar; 53(2):233-242. PubMed ID: 29888622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal and Infant Mortality in Korea, Japan, and the U.S.: Effect of Birth Weight Distribution and Birth Weight-Specific Mortality Rates.
    Kim do H; Jeon J; Park CG; Sriram S; Lee KS
    J Korean Med Sci; 2016 Sep; 31(9):1450-4. PubMed ID: 27510390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the introduction of a nationwide DUR system where local DUR systems are operating--The Korean experience.
    Yang JH; Kim M; Park YT; Lee EK; Jung CY; Kim S
    Int J Med Inform; 2015 Nov; 84(11):912-9. PubMed ID: 26363001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States.
    Hoshino Y; Narukawa M
    Ther Innov Regul Sci; 2022 Sep; 56(5):839-847. PubMed ID: 35877034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraindication labelling changes in the United States and Germany.
    Garbe E; Andersohn F
    Eur J Clin Pharmacol; 2007 Jan; 63(1):87-93. PubMed ID: 17124576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of prescription drug costs in the United States and the United Kingdom, part 3: methylphenidate.
    Jick H; Wilson A; Wiggins P; Chamberlin DP
    Pharmacotherapy; 2012 Nov; 32(11):970-3. PubMed ID: 23108719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-national comparison of 17 countries' insulin glargine drug labels.
    Polinski JM; Kesselheim AS; Seeger JD; Connolly JG; Choudhry NK; Shrank WH
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):159-65. PubMed ID: 25250724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.